参考文献/References:
[1]BAI Jing, SUN Qian, ZHAI Hui. A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean delivery[J]. Experimental and Therapeutic Medicine, 2014, 7(1): 46-50.
[2]BARNEY O J, HAUGHNEY R, BILOLIKAR A. A case of pulmonary oedema secondary to carboprost[J]. Journal of Obstetrics and Gynaecology, 2012, 32(6): 597-599.
[3]陈章玲,曹德权,徐军美,等.右美托咪定镇静时BIS与OAA/S评分的相关性研究[J].临床麻醉学杂志,2014,30(5):434-436.
[4]付晨薇,刘俊涛.如何规范产后出血的药物治疗 [J].中国实用妇科与产科杂志,2014,30(4):262-265.
[5]汪新妮,彭幼,朱燕虹.预防性宫体注射卡前列素氨丁三醇在产后出血高危因素孕妇剖宫产术中的效果 [J].广东医学,2012,33(5):696-697.
[6]BLUM J, WINIKOFF B, RAGHAVAN S, et al. Treatment of post-hemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin:a double-blind,randomized,noninferiority trial [J]. Lancet, 2010, 375(9710): 217-223.
[7]中华医学会妇产科学分会产科学组.产后出血预防与处理指南(草案) [J].中华妇产科杂志,2009,44(7):554-557.
[8]谢菡,葛卫红.哌替啶用于分娩镇痛的研究进展 [J].现代药物与临床,2014,29(3):322-326.
[9]胡凤珍,费杭模.硬膜外阻滞剖宫产术胎儿娩出前用哌替啶氟哌啶的观察 [J].临床麻醉学杂志,1996,12(2): 106.